Timothy Edwin Kelly - 14 Nov 2025 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Role
Chief Financial Officer
Signature
/s/ Alex Nemiroff, as Attorney-in-Fact
Issuer symbol
PRAX
Transactions as of
14 Nov 2025
Net transactions value
+$12,142
Form type
4
Filing time
21 Nov 2025, 21:42:37 UTC
Previous filing
19 May 2025
Next filing
09 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kelly Timothy Edwin Chief Financial Officer C/O PRAXIS PRECISION MEDICINES, INC., 99 HIGH STREET, 30TH FLOOR, BOSTON /s/ Alex Nemiroff, as Attorney-in-Fact 21 Nov 2025 0001863297

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRAX Common Stock Award $12,142 +384 +1.6% $31.62 24,663 14 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).